The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Androgens and estrogens in benign prostatic hyperplasia: Past, present and future
Open accessAbstract
Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) are common clinical problems in urology. While the precise molecular etiology remains unclear, sex steroids have been implicated in the development and maintenance of BPH. Sufficient data exists linking androgens and androgen receptor pathways to BPH and use of androgen reducing compounds, such as 5α-reductase inhibitors which block the conversion of testosterone into dihydrotestosterone, are a component of the standard of care for men with LUTS attributed to an enlarged prostate. However, BPH is a multifactorial disease and not all men respond well to currently available treatments, suggesting factors other than androgens are involved. Testosterone, the primary circulating androgen in men, can also be metabolized via CYP19/aromatase into the potent estrogen, estradiol-17β. The prostate is an estrogen target tissue and estrogens directly and indirectly affect growth and differentiation of prostate. The precise role of endogenous and exogenous estrogens in directly affecting prostate growth and differentiation in the context of BPH is an understudied area. Estrogens and selective estrogen receptor modulators (SERMs) have been shown to promote or inhibit prostate proliferation signifying potential roles in BPH. Recent research has demonstrated that estrogen receptor signaling pathways may be important in the development and maintenance of BPH and LUTS; however, new models are needed to genetically dissect estrogen regulated molecular mechanisms involved in BPH. More work is needed to identify estrogens and associated signaling pathways in BPH in order to target BPH with dietary and therapeutic SERMs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Huggins, C., & Hodges, C. V. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64820-3 · Cited by 3,855
editor-in-chief, A. J. W. (2012) · Elsevier eBooks · Cited by 2,682
The Development of Human Benign Prostatic Hyperplasia with Age
Berry, S. J., Coffey, D. S., Walsh, P. C., & Ewing, L. L. (1984) · Journal of Urology · doi:10.1016/s0022-5347(17)49698-4 · Cited by 2,488
Exposure of the U.S. Population to Bisphenol A and 4- tertiary -Octylphenol: 2003–2004
Calafat, A. M., Ye, X., Wong, L.-Y., Reidy, J. A., & Needham, L. L. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.10753 · Cited by 1,743
Generation and reproductive phenotypes of mice lacking estrogen receptor β
Krege, J. H., Hodgin, J. B., Couse, J. F., Enmark, E., Warner, M., Mahler, J. F., Sar, M., Korach, K. S., Gustafsson, J.-Å., & Smithies, O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15677 · Cited by 1,691
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591
Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium
Olumi, A., Grossfeld, G., Hayward, S., Carroll, P., Cunha, G., Hein, P., & Tlsty, T. (2000) · Breast Cancer Research · doi:10.1186/bcr138 · Cited by 1,463
Björnström, L., & Sjöberg, M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0486 · Cited by 1,362
GRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118
Androgen Deprivation Therapy for Prostate Cancer
Sharifi, N. (2005) · JAMA · doi:10.1001/jama.294.2.238 · Cited by 1,083
Oxysterols and atherosclerosis
Brown, A. J., & Jessup, W. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00196-8 · Cited by 919
Guo, Z., Yang, X., Sun, F., Jiang, R., Linn, D. E., Chen, H., Chen, H., Kong, X., Melamed, J., Tepper, C. G., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3795 · Cited by 880
Ho, S.-M., Tang, W.-Y., Belmonte de Frausto, J., & Prins, G. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0516 · Cited by 796
The pros and cons of phytoestrogens
Patisaul, H. B., & Jefferson, W. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.03.003 · Cited by 746
Huggins, C., & Hodges, C. V. (2002) · Journal of Urology · doi:10.1016/s0022-5347(02)80307-x · Cited by 716
Saal, F. S. V., Timms, B. G., Montano, M. M., Palanza, P., Thayer, K. A., Nagel, S. C., Dhar, M. D., Ganjam, V. K., Parmigiani, S., & Welshons, W. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.2056 · Cited by 701
Progressive proximal spinal and bulbar muscular atrophy of late onset: A sex-linked recessive trait
Kennedy, W. R., Alter, M., & Sung, J. H. (1998) · Neurology · doi:10.1212/wnl.50.3.583 · Cited by 679
Watson, P. A., Chen, Y. F., Balbas, M. D., Wongvipat, J., Socci, N. D., Viale, A., Kim, K., & Sawyers, C. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012443107 · Cited by 639
Origin and evolution of benign prostatic enlargement.
McNeal, J. E. (1978) · PubMed · Cited by 539
Extranuclear Steroid Receptors: Nature and Actions
Hammes, S. R., & Levin, E. R. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0022 · Cited by 475
Ferrini, R. L., & Barrett-Connor, E. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009519 · Cited by 473
Vermeulen, A., Kaufman, J. M., Goemaere, S., & Van Pottelberg, I. (2002) · The Aging Male · doi:10.1080/tam.5.2.98.102 · Cited by 452
Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men
Belanger, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.4.1086 · Cited by 438
GRINO, P. B., GRIFFIN, J. E., & WILSON, J. D. (1990) · Endocrinology · doi:10.1210/endo-126-2-1165 · Cited by 432
Benign prostatic hyperplasia: an overview
Ziada, A., Rosenblum, M., & Crawford, E. D. (1999) · Urology · doi:10.1016/s0090-4295(98)00532-9 · Cited by 431
The induction of prostatic hypertrophy in the dog with androstanediol.
Walsh, P. C., & Wilson, J. D. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108353 · Cited by 418
Dihydrotestosterone in prostatic hypertrophy
Siiteri, P. K., & Wilson, J. D. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106391 · Cited by 406
27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen
Umetani, M., Domoto, H., Gormley, A. K., Yuhanna, I. S., Cummins, C. L., Javitt, N. B., Korach, K. S., Shaul, P. W., & Mangelsdorf, D. J. (2007) · Nature Medicine · doi:10.1038/nm1641 · Cited by 396
Timms, B. G., Howdeshell, K. L., Barton, L., Bradley, S., Richter, C. A., & vom Saal, F. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502544102 · Cited by 394
The role of dihydrotestosterone in benign prostatic hyperplasia
Carson, C., & Rittmaster, R. (2003) · Urology · doi:10.1016/s0090-4295(03)00045-1 · Cited by 392
Soy Isoflavones and Cancer Prevention: CLINICAL SCIENCE REVIEW
Sarkar, F. H., & Li, Y. (2003) · Cancer Investigation · doi:10.1081/cnv-120023773 · Cited by 383
Role of the stromal microenvironment in carcinogenesis of the prostate
Cunha, G. R., Hayward, S. W., Wang, Y. Z., & Ricke, W. A. (2003) · International Journal of Cancer · doi:10.1002/ijc.11335 · Cited by 374
Self-citationPathology of Benign Prostatic Hyperplasia
McNeal, J. E. (1990) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)00961-7 · Cited by 370
Cali, J. J., & Russell, D. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89517-9 · Cited by 368
Estrogen receptor β acts as a dominant regulator of estrogen signaling
Pettersson, K., Delaunay, F., & Gustafsson, J.-Å. (2000) · Oncogene · doi:10.1038/sj.onc.1203828 · Cited by 362
Hsieh, T.-C., & Wu, J. M. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4471 · Cited by 361
Hayward, S. W., Dahiya, R., Cunha, G. R., Bartek, J., Deshpande, N., & Narayan, P. (1995) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02631333 · Cited by 340
Pathology of benign prostatic hyperplasia. Insight into etiology.
McNeal, J. E. (1990) · PubMed · Cited by 334
The role of estrogens and estrogen receptors in normal prostate growth and disease
Prins, G. S., & Korach, K. S. (2008) · Steroids · doi:10.1016/j.steroids.2007.10.013 · Cited by 332
Weihua, Z., Lathe, R., Warner, M., & Gustafsson, J.-Å. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162477299 · Cited by 328
Benign prostatic hyperplasia: an overview.
Roehrborn, C. G. (2005) · Europe PMC (PubMed Central) · Cited by 316
Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development
Cunha, G. R., Ricke, W., Thomson, A., Marker, P. C., Risbridger, G., Hayward, S. W., Wang, Y. Z., Donjacour, A. A., & Kurita, T. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.10.017 · Cited by 310
Self-citationOlsen, E. A., Hordinsky, M., Whiting, D., Stough, D., Hobbs, S., Ellis, M. L., Wilson, T., & Rittmaster, R. S. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.007 · Cited by 303
Cunha, G. R., & Lung, B. (1978) · Journal of Experimental Zoology · doi:10.1002/jez.1402050203 · Cited by 302
27-Hydroxycholesterol Is an Endogenous Selective Estrogen Receptor Modulator
DuSell, C. D., Umetani, M., Shaul, P. W., Mangelsdorf, D. J., & McDonnell, D. P. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0383 · Cited by 301
Cordon-Cardo, C., Koff, A., Drobnjak, M., Capodieci, P., Osman, I., Millard, S. S., Gaudin, P. B., Fazzari, M., Zhang, Z.-F., Massague, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.17.1284 · Cited by 300
Prins, G. S., Birch, L. A., Couse, J. F., Choi, I., Katzenellenbogen, B. S., & Korach, K. S. (2001) · PubMed · Cited by 291
Shapiro, E., Becich, M. J., Hartanto, V., & Lepor, H. (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)37546-8 · Cited by 291
Comparison of spontaneous and experimentally induced canine prostatic hyperplasia.
DeKlerk, D. P., Coffey, D. S., Ewing, L. L., McDermott, I. R., Reiner, W. G., Robinson, C. H., Scott, W. W., Strandberg, J. D., Talalay, P., Walsh, P. C., et al. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109532 · Cited by 283
Resveratrol commonly displays hormesis: Occurrence and biomedical significance
Calabrese, E. J., Mattson, M. P., & Calabrese, V. (2010) · Human & Experimental Toxicology · doi:10.1177/0960327110383625 · Cited by 273
Endocrine disruptors and estrogenic effects on male reproductive axis
Sikka, S. C., & Wang, R. (2008) · Asian Journal of Andrology · doi:10.1111/j.1745-7262.2008.00370.x · Cited by 264
Novel 5α‐steroid reductase (SRD5A3, type‐3) is overexpressed in hormone‐refractory prostate cancer
Uemura, M., Tamura, K., Chung, S., Honma, S., Okuyama, A., Nakamura, Y., & Nakagawa, H. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00656.x · Cited by 263
A and B forms of the androgen receptor are expressed in a variety of human tissues
Wilson, C. M., & McPhaul, M. J. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(96)03819-1 · Cited by 262
The int-2 gene product acts as an epithelial growth factor in transgenic mice.
Muller, W. J., Lee, F. S., Dickson, C., Peters, G., Pattengale, P., & Leder, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08188.x · Cited by 254
Smith, M. R., Fallon, M. A., Lee, H., & Finkelstein, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032058 · Cited by 248
Serenoa repens for benign prostatic hyperplasia
Tacklind, J., MacDonald, R., Rutks, I., Stanke, J. U., & Wilt, T. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001423.pub2 · Cited by 240
Clinical and Experimental Studies of Benign Prostatic Hyperplasia
Coffey, D. S., & Walsh, P. C. (1990) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)00960-5 · Cited by 228
Ricke, W. A., McPherson, S. J., Bianco, J. J., Cunha, G. R., Wang, Y., & Risbridger, G. P. (2008) · The FASEB Journal · doi:10.1096/fj.07-9526com · Cited by 213
Self-citationWu, C.-T., Altuwaijri, S., Ricke, W. A., Huang, S.-P., Yeh, S., Zhang, C., Niu, Y., Tsai, M.-Y., & Chang, C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704940104 · Cited by 211
Self-citationThe Dual, Opposing Roles of Estrogen in the Prostate
Ellem, S. J., & Risbridger, G. P. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04360.x · Cited by 211
Estrogen and androgen signaling in the pathogenesis of BPH
Ho, C. K. M., & Habib, F. K. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2010.207 · Cited by 209
Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system
Kurita, T., Wang, Y. Z., Donjacour, A. A., Zhao, C., Lydon, J. P., O'Malley, B. W., Isaacs, J. T., Dahiya, R., & Cunha, G. R. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400797 · Cited by 203
Donjacour, A. A. (1993) · Endocrinology · doi:10.1210/en.132.6.2342 · Cited by 200
Li, Y., Alsagabi, M., Fan, D., Bova, G. S., Tewfik, A. H., & Dehm, S. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1998 · Cited by 199
McPherson, S. J., Hussain, S., Balanathan, P., Hedwards, S. L., Niranjan, B., Grant, M., Chandrasiri, U. P., Toivanen, R., Wang, Y., Taylor, R. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905524107 · Cited by 197
Influence of Age and Endocrine Factors on the Volume of Benign Prostatic Hyperplasia
Partin, A. W., Oesterling, J. E., Epstein, J. I., Horton, R., & Walsh, P. C. (1991) · Journal of Urology · doi:10.1016/s0022-5347(17)38353-2 · Cited by 196
Ho, S. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10759 · Cited by 196
THE RESULTS OF DOUBLE CASTRATION IN HYPERTROPHY OF THE PROSTATE
WHITE, J. W. (1895) · Annals of Surgery · doi:10.1097/00000658-189507000-00001 · Cited by 193
Tissue content of dihydrotestosterone in human prostatic hyperplasis is not supranormal.
Walsh, P. C., Hutchins, G. M., & Ewing, L. L. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111137 · Cited by 175
Price, D., Stein, B., Sieber, P., Tutrone, R., Bailen, J., Goluboff, E., Burzon, D., Bostwick, D., Steiner, M., & GTx-006-221 Study Team (2006) · Journal of Urology · doi:10.1016/j.juro.2006.04.011 · Cited by 172
Stanbrough, M., Leav, I., Kwan, P. W. L., Bubley, G. J., & Balk, S. P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191235898 · Cited by 169
Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Smith, M. R., Morton, R. A., Barnette, K. G., Sieber, P. R., Malkowicz, S. B., Rodriguez, D., Hancock, M. L., & Steiner, M. S. (2013) · Journal of Urology · doi:10.1016/j.juro.2012.11.016 · Cited by 160
Prins, G. S., Ye, S.-H., Birch, L. A., Ho, S., & Kannan, K. (2010) · Reproductive Toxicology · doi:10.1016/j.reprotox.2010.09.009 · Cited by 158
Davies, P., & Eaton, C. L. (1991) · Journal of Endocrinology · doi:10.1677/joe.0.1310005 · Cited by 158
Chodak, G. W., Kranc, D. M., Puy, L. A., Takeda, H., Johnson, K. L., & Chang, C. (1992) · The Journal of Urology · doi:10.1016/s0022-5347(17)37389-5 · Cited by 157
Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model.
Raghow, S., Hooshdaran, M. Z., Katiyar, S., et al. (2002) · PubMed · Cited by 155
Prostate visualization studies in males homozygous and heterozygous for 5 alpha-reductase deficiency
Imperato‐McGinley, J., Gautier, T., Zirinsky, K., Hom, T., Palomo, O., Stein, E. A., Vaughan, E. D., Markísz, J. A., de Arellano, E. R., & Kazam, E. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.4.1400866 · Cited by 154
Gann, P. H., Hennekens, C. H., Grodstein, F., Stampfer, M. J., Longcope, C., & Verhoek, W. G. (1995) · The Prostate · doi:10.1002/pros.2990260109 · Cited by 150
Benign Prostatic Hyperplasia and Its Aetiologies
Briganti, A., Umberto Capitanio, A., Suardi, N. R., Andrea Gallina, A., Salonia, A., Bianchi, M., Tutolo, M., Girolamo, V. D., Guazzoni, G. F., Rigatti, P., et al. (2009) · European Urology Supplements · doi:10.1016/j.eursup.2009.11.002 · Cited by 148
Tremblay, G. B., Tremblay, A., Labrie, F., & Giguère, V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1919 · Cited by 141
Repressors of Androgen and Progesterone Receptor Action
Agoulnik, I. U., Krause, W. C., Bingman, W. E., Rahman, H., Amrikachi, M., Ayala, G. E., & Weigel, N. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305153200 · Cited by 141
Unexpected Virilization in Male Mice Lacking Steroid 5 -Reductase Enzymes
Mahendroo, M., Cala, K. M., Hess, D. L., & Russell, D. W. (2001) · Endocrinology · doi:10.1210/endo.142.11.8510 · Cited by 139
COMPARISON OF ANDROGEN METABOLITES IN BENIGN PROSTATIC HYPERTROPHY (BPH) AND NORMAL PROSTATE
Geller, J., Albert, J., Lopez, D., Geller, S., & Niwayama, G. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-43-3-686 · Cited by 138
Textbook of Benign Prostatic Hyperplasia
Bosch, J. L. H. R., & Schroder, F. H. (1996) · BMJ · doi:10.1136/bmj.313.7056.567 · Cited by 137
Serum sex hormones and measures of benign prostatic hyperplasia
Roberts, R. O., Jacobson, D. J., Rhodes, T., Klee, G. G., Leiber, M. M., & Jacobsen, S. J. (2004) · The Prostate · doi:10.1002/pros.20080 · Cited by 136
Monroe, D. G., Secreto, F. J., Subramaniam, M., Getz, B. J., Khosla, S., & Spelsberg, T. C. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0381 · Cited by 133
Soy isoflavone genistein in prevention and treatment of prostate cancer
Perabo, F., Löw, E. C. V., Ellinger, J., von Rücker, A., Müller, S. C., & Bastian, P. J. (2007) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4501000 · Cited by 129
The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia
Giovannucci, E. L., Platz, E. A., Stampfer, M. J., Chan, A. T., Krithivas, K., Kawachi, I. I., Willett, W. C., & Kantoff, P. W. (1999) · Urology · doi:10.1016/s0090-4295(98)00468-3 · Cited by 128
Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Smith, M. R., Morton, R. A., Barnette, K. G., SIEBER, P. R., Malkowicz, S. B., Rodriguez, D., Hancock, M. L., & Steiner, M. S. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.06.022 · Cited by 124
Estrogen Signaling via Estrogen Receptor β
Zhao, C., Dahlman‐Wright, K., & Gustafsson, J.-Α. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.180109 · Cited by 123
Treating prostate cancer: a rationale for targeting local oestrogens
Ellem, S. J., & Risbridger, G. P. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2174 · Cited by 121
Barclay, W. W., Woodruff, R. D., Hall, M. C., & Cramer, S. D. (2004) · Endocrinology · doi:10.1210/en.2004-1123 · Cited by 121
Herrera, V. L. M., Makrides, S. C., Xie, H. X., Adari, H. Y., Krauss, R. M., Ryan, U. S., & Ruiz‐Opazo, N. (1999) · Nature Medicine · doi:10.1038/70956 · Cited by 120
Beta-sitosterols for benign prostatic hyperplasia
Wilt, T. J., Ishani, A., MacDonald, R. H., Stark, G., Mulrow, C. D., & Lau, J. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001043 · Cited by 120
[Serenoa repens in benign prostatic hyperplasia].
Log, T. (2008) · PubMed · Cited by 117
Prostate Hyperplasia in a Transgenic Mouse with Prostate-Specific Expression of Prolactin
Kindblom, J., Dillner, K., Sahlin, L., Robertson, F. G., Ormandy, C. J., Törnell, J., & Wennbo, H. (2003) · Endocrinology · doi:10.1210/en.2002-0187 · Cited by 115
Intermolecular interactions identify ligand-selective activity of estrogen receptor α/β dimers
Powell, E., & Xu, W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807274105 · Cited by 114
Titus-Ernstoff, L. T., Troisi, R. J., Hatch, E. E., Palmer, J. R., Hyer, M., Kaufman, R. H., Adám, E., Noller, K. L., & Hoover, R. N. (2009) · International Journal of Andrology · doi:10.1111/j.1365-2605.2009.01010.x · Cited by 113
Androgen Replacement Therapy and Prostate Safety
Morales, Á. (2002) · European Urology · doi:10.1016/s0302-2838(01)00039-2 · Cited by 105
Carilla, E., Briley, M., Fauran, F., Sultan, C., & Duvilliers, C. (1984) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(84)90265-6 · Cited by 104
Silverio, F. D., D'Eramo, G., Lubrano, C., et al. (1992) · European Urology · doi:10.1159/000474863 · Cited by 103
Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells
Hsu, A., Bray, T. Μ., Helferich, W. G., Doerge, D. R., & Ho, E. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2009.009128 · Cited by 101
Transdermal Estradiol Therapy for Advanced Prostate Cancer—Forward to the Past?
Ockrim, J., Lalani, E., Laniado, M., Carter, S. S. C., & Abel, P. D. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000061024.75334.40 · Cited by 97
Textbook of benign prostatic hyperplasia
Kirby, R. S., McConnell, J. D., Fitzpatrick, J. M., Roehrborn, C. G., & Boyle, P. (1996) · Medical Entomology and Zoology · Cited by 89
Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia
Hammarsten, J., Damber, J., Karlsson, M. K., Knutson, T., Ljunggren, Ö., Ohlsson, C., Peeker, R., Smith, U., & Mellström, D. (2008) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2008.50 · Cited by 89
Steroid hormones stimulate human prostate cancer progression and metastasis
Ricke, W. A., Ishii, K., Ricke, E. A., Simko, J. P., Wang, Y. Z., Hayward, S. W., & Cunha, G. R. (2005) · International Journal of Cancer · doi:10.1002/ijc.21614 · Cited by 88
Self-citationSimanainen, U., Allan, C. M., Lim, P., McPherson, S. J., Jimenez, M., Zajac, J. D., Davey, R. A., & Handelsman, D. J. (2007) · Endocrinology · doi:10.1210/en.2006-1223 · Cited by 86
Estrogenic effects on prostatic differentiation and carcinogenesis
Cunha, G. R., Wang, Y. Z., Hayward, S. W., & Risbridger, G. P. (2001) · Reproduction Fertility and Development · doi:10.1071/rd01010 · Cited by 86
ERβ: recent understanding of estrogen signaling
Sugiyama, N., Barros, R. P. A., Warner, M. N., & Gustafsson, J.-Å. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.05.001 · Cited by 83
Smith, M. R., Malkowicz, S. B., Chu, F. M., Forrest, J. B., SIEBER, P. R., Barnette, K. G., Rodriquez, D., & Steiner, M. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5517 · Cited by 80
de Oliveira, A. G., Coelho, P. H., Guedes, F. D., Mahecha, G. A. B., Hess, R. A., & Oliveira, C. A. (2007) · Steroids · doi:10.1016/j.steroids.2007.08.001 · Cited by 80
The effects of chronic high dose androgen or estrogen treatment on the human prostate [corrected].
Jin, B., Turner, L., Walters, W. A. W., & Handelsman, D. J. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954029 · Cited by 80
Mortality in men admitted to hospital with acute urinary retention: database analysis
Armitage, J. N., Sibanda, N., Cathcart, P. J., Emberton, M., & van der Meulen, J. (2007) · BMJ · doi:10.1136/bmj.39377.617269.55 · Cited by 74
Androgen receptor CAG polymorphism and prostate cancer risk
Mononen, N., Ikonen, T., Autio, V., Rökman, A., Matikainen, M. P., Tammela, T. L. J., Kallioniemi, O., Koivisto, P. A., & Schleutker, J. (2002) · Human Genetics · doi:10.1007/s00439-002-0776-5 · Cited by 74
Burnett‐Bowie, S. M., Roupenian, K. C., Dere, M. E., Lee, H., & Leder, B. Z. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03327.x · Cited by 73
Giovannucci, E. L., Stampfer, M. J., Chan, A. T., Krithivas, K., Gann, P. H., Hennekens, C. H., & Kantoff, P. W. (1999) · The Prostate · Cited by 71
Estrogen receptor β expression in human prostate tissue
Pasquali, D., Staibano, S., Prezioso, D., Franco, R., Esposito, D., Notaro, A., Rosa, G. D., Bellastella, A., & Sinisi, A. A. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00418-x · Cited by 68
Steroid hormones and carcinogenesis of the prostate: the role of estrogens
Ricke, W. A., Wang, Y. Z., & Cunha, G. R. (2007) · Differentiation · doi:10.1111/j.1432-0436.2007.00224.x · Cited by 65
Self-citationHenley, D. V., & Korach, K. S. (2010) · HORMONES · doi:10.14310/horm.2002.1270 · Cited by 63
Significance of the polyglutamine tract polymorphism in the androgen receptor
Casella, R., Maduro, M. R., Lipshultz, L. I., & Lamb, D. J. (2001) · Urology · doi:10.1016/s0090-4295(01)01401-7 · Cited by 56
Expression of steroidogenic enzymes and sex-steroid receptors in human prostate
Pelletier, G. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.02.004 · Cited by 56
Repressive Effects of Resveratrol on Androgen Receptor Transcriptional Activity
Shi, W., Leong, M., Cho, E., Farrell, J., Chen, H., Tian, J., & Zhang, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007398 · Cited by 51
Jin, B. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.12.4290 · Cited by 48
Kim, H., Andersson, L. C., Bouton, D., Warner, M. N., & Gustafsson, J.-Α. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811295106 · Cited by 45
Unexpected Virilization in Male Mice Lacking Steroid 5 -Reductase Enzymes
Mahendroo, M. (2001) · Endocrinology · doi:10.1210/en.142.11.4652 · Cited by 44
Genetic polymorphism and pathogenesis of benign prostatic hyperplasia
Konwar, R., Chattopadhyay, N., & Bid, H. K. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07667.x · Cited by 43
Gingell, J. C., Knönagel, H., Kurth, K. H., & Tunn, U. W. (1995) · The Journal of Urology · doi:10.1016/s0022-5347(01)67061-7 · Cited by 43
Stone, N. N., & Clejan, S. (1991) · Journal of Andrology · doi:10.1002/j.1939-4640.1991.tb00278.x · Cited by 42
Schauer, I. G., Ressler, S. J., & Rowley, D. R. (2008) · The Prostate · doi:10.1002/pros.20886 · Cited by 40
Effect of tamoxifen citrate on reproductive parameters of male dogs
Corrada, Y. (2003) · Theriogenology · doi:10.1016/j.theriogenology.2003.07.020 · Cited by 39
Bisphenol A induces permanent squamous change in mouse prostatic epithelium
Ogura, Y., Ishii, K., Kanda, H., Kanai, M., Arima, K., Wang, Y. Z., & Sugimura, Y. (2007) · Differentiation · doi:10.1111/j.1432-0436.2007.00177.x · Cited by 38
Winter, M. L., Liehr, J. G., Bosland, M. C., Wade, D. R., Falvo, R. E., & Nagamani, M. (1995) · The Prostate · doi:10.1002/pros.2990260608 · Cited by 38
Urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-β signaling
Li, X., Wang, Y., Sharif‐Afshar, A., Uwamariya, C., Yi, A., Ishii, K., Hayward, S. W., Matusik, R. J., & Bhowmick, N. A. (2009) · Differentiation · doi:10.1016/j.diff.2008.09.012 · Cited by 38
Nonhuman primates as models for studies of prostate specific antigen and prostatic diseases
Mubiru, J. N., Hubbard, G. B., Dick, E. J., Furman, J., Troyer, D. A., & Rogers, J. (2008) · The Prostate · doi:10.1002/pros.20814 · Cited by 38
Transgenic Mice Overexpressing the Prolactin Gene Develop Dramatic Enlargement of the Prostate Gland
Wennbo, H., Kindblom, J. M., Isaksson, O. G. P., & Törnell, J. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)63632-2 · Cited by 37
Androgen Receptor Gene Polymorphism and Prostate Zonal Volumes in Australian and Chinese Men
Jin, B., Beilin, J., Zajac, J. D., & Handelsman, D. J. (2000) · Journal of Andrology · doi:10.1002/j.1939-4640.2000.tb03280.x · Cited by 34
Effects of the new steroidal antiandrogen TZP‐4238 on hormone‐induced canine prostatic hyperplasia
Takezawa, Y., Fukabori, Y., Yamanaka, H., Mieda, M., Honma, S., Kushitani, M., & Hamataki, N. (1992) · The Prostate · doi:10.1002/pros.2990210408 · Cited by 34
Association Between Lower Urinary Tract Symptoms and Serum Levels of Sex Hormones in Men
Miwa, Y., Kaneda, T., & Yokoyama, O. (2008) · Urology · doi:10.1016/j.urology.2008.04.023 · Cited by 34
DHEA metabolism in prostate: For better or worse?
Arnold, J. T. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.019 · Cited by 31
Sex, drugs and gene expression: signalling by members of the nuclear receptor superfamily
McEwan, I. J. (2004) · Essays in Biochemistry · doi:10.1042/bse0400001 · Cited by 30
Identification of components of Prunus africana extract that inhibit lipid peroxidation
Hass, M. A., Nowak, D. M., Leonova, E. V., Levin, R. M., & Longhurst, P. A. (1999) · Phytomedicine · doi:10.1016/s0944-7113(99)80063-4 · Cited by 26
Meikle, A. W., McWhorter, W. P., Stephenson, R. A., Middleton, R. G., & Skolnick, M. H. (1995) · The Prostate · doi:10.1002/pros.2990260505 · Cited by 26
The Androgen Receptor's CAG/Glutamine Tract in Mouse Models of Neurological Disease and Cancer
Lieberman, A. P., & Robins, D. M. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14212 · Cited by 25
Narayan, P. A., Trachtenberg, J., Lepor, H., Debruyne, E. J., Tewari, A. K., Stone, N. N., Das, S. P., Jimenez-Cruz, J. E., Shearer, R. J., Klimberg, I. W., et al. (1996) · Urology · doi:10.1016/s0090-4295(99)80484-1 · Cited by 24
Roberts, K. P., Iyer, R. A., Prasad, G., Liu, L. T., Lind, R. E., & Hanna, P. E. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980201)34:2<75::aid-pros1>3.0.co;2-i · Cited by 21
Atamestane, a New Aromatase Inhibitor for the Management of Benign Prostatic Hyperplasia
Etreby, M. F. E., Nishino, Y., Habenicht, U., et al. (1991) · Journal of Andrology · doi:10.1002/j.1939-4640.1991.tb00283.x · Cited by 20
Gonzalez, G., Guendulain, C., Maffrand, C. I., & Gobello, C. (2009) · Reproduction in Domestic Animals · doi:10.1111/j.1439-0531.2009.01379.x · Cited by 20
Nomura, H., Kawashima, H., Masaki, S., Hosono, T. Y., Matsumura, K., Tamada, S., Tanaka, T., & Nakatani, T. (2009) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2009.20 · Cited by 18
Meikle, A. W. (2009) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(09)79269-8 · Cited by 6
(1999) · doi:10.1002/(sici)1097-0045(19991201)41:4<253::aid-pros5>3.0.co;2-9
Cited by
Bisphenol A and Reproductive Health: Update of Experimental and Human Evidence, 2007–2013
Peretz, J., Vrooman, L., Ricke, W. A., Hunt, P. A., Ehrlich, S., Hauser, R., Padmanabhan, V., Taylor, H. S., Swan, S. H., VandeVoort, C. A., et al. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1307728 · Cited by 555
Self-citationBenign prostatic hyperplasia – what do we know?
Devlin, C. M., Simms, M. S., & Maitland, N. J. (2021) · BJU International · doi:10.1111/bju.15229 · Cited by 287
Li, Z., Hu, S., Liu, Z., Zhang, M., Chen, S., Yu, W., Ding, M., Fan, Y., Li, S., & Jin, J. (2026) · International Journal of Biological Sciences · doi:10.7150/ijbs.130242
“Several factors have been implicated in the underlying pathogenesis of BPH, including cellular senescence, inflammation, and hormonal alterations [7,8].”
Metadata
- Authors
- Nicholson, T. M., & Ricke, W. A.
- Venue
- Differentiation
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 82
- Issue
- 4-5
- Pages
- 184-199
- ISSN
- 0301-4681 (ISSN-L)
- OpenAlex
- W2052268441
- Cited by
- 331
- References
- 150
- FWCI
- 18.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.